ALK Activation as a target of TRAanslational Science (ALKATRAS): Break free from cancer

Informazioni relative al progetto

ALKATRAS

ID dell’accordo di sovvenzione: 675712

DOI

10.3030/675712

Progetto chiuso

Data della firma CE 31 Luglio 2015

Data di avvio 1 Settembre 2015

Data di completamento 31 Agosto 2019

Finanziato da

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Costo totale

€ 3 849 199,56

Contributo UE

€ 3 849 199,56

Coordinato da

THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE
United Kingdom

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (3)

Research article publication

Research articles will be published detailing the research findings from the ALKATRAS network

ALK review

A series of review articles will be prepared and published in the scientific literature

Dissemination reporting

A report will be prepared containing an overview of all outreach and dissemination activities carried out and achieved during the course of the ETN

Websites, patent fillings, videos etc. (7)

ALCL transcriptome database

A database will be developed that details the transcriptome of ALCL. This will be available to the wider scientific community.

Therapies for resistant disease database

A database will be produced detailing therapies that can be used for the treatment of ALK-related cancers that are resistant to other forms of therapy

Therapy Synergism database

A database will be developed to aid clinicians in the treatment of patients with ALK-related malignancies. The database will detail those therapeutic compounds that have synergy

Mutations database

A database will be produced detailing somatic and acquired mutations in ALCL.

Epigenetics database

A database will be developed detailing deregulated cpG islands in ALK-related cancers which will be available to the wider scientific community

Podcasts

Students will produce podcasts detailing their research that will be accessible to teh general public and the scientific community.

ALKATRAS website developed and updated

An ALKATRAS website will be developed and continually updated

Other (2)

Outreach

Students will undertake outreach activities to present their research to the scientific community and the general public

Award of PhD degrees

All students would have been awarded their PhD degrees and this will be announced on the ALKATRAS website.

Pubblicazioni

Peer reviewed articles (31)

The Pathological Spectrum of Systemic Anaplastic Large Cell Lymphoma (ALCL)

Autori: Ivonne Montes-Mojarro, Julia Steinhilber, Irina Bonzheim, Leticia Quintanilla-Martinez, Falko Fend
Pubblicato in: Cancers, Numero 10/4, 2018, Pagina/e 107, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10040107

Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes

Autori: Geeta Sharma, Ines Mota, Luca Mologni, Enrico Patrucco, Carlo Gambacorti-Passerini, Roberto Chiarle
Pubblicato in: Cancers, Numero 10/3, 2018, Pagina/e 62, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10030062

Treatment Options for Paediatric Anaplastic Large Cell Lymphoma (ALCL): Current Standard and beyond

Autori: Nina Prokoph, Hugo Larose, Megan Lim, G. Burke, Suzanne Turner
Pubblicato in: Cancers, Numero 10/4, 2018, Pagina/e 99, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10040099

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability

Autori: Cosimo Lobello, Vasilis Bikos, Andrea Janikova, Sarka Pospisilova
Pubblicato in: Cancers, Numero 10/3, 2018, Pagina/e 64, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10030064

The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas

Autori: Ines Garces de los Fayos Alonso, Huan-Chang Liang, Suzanne Turner, Sabine Lagger, Olaf Merkel, Lukas Kenner
Pubblicato in: Cancers, Numero 10/4, 2018, Pagina/e 93, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10040093

Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma

Autori: Serena Stadler, Vijay Singh, Fabian Knörr, Christine Damm-Welk, Wilhelm Woessmann
Pubblicato in: Cancers, Numero 10/4, 2018, Pagina/e 114, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10040114

Targeting Autophagy in ALK-Associated Cancers

Autori: Julie Frentzel, Domenico Sorrentino, Sylvie Giuriato
Pubblicato in: Cancers, Numero 9/12, 2017, Pagina/e 161, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers9120161

The AP-1-BATF and -BATF3 module is essential for growth, survival and TH17/ILC3 skewing of anaplastic large cell lymphoma

Autori: Nikolai Schleussner, Olaf Merkel, Mariantonia Costanza, Huan-Chang Liang, Franziska Hummel, Chiara Romagnani, Pawel Durek, Ioannis Anagnostopoulos, Michael Hummel, Korinna Jöhrens, Antonia Niedobitek, Patrick R. Griffin, Roberto Piva, Henrike L. Sczakiel, Wilhelm Woessmann, Christine Damm-Welk, Christian Hinze, Dagmar Stoiber, Bernd Gillissen, Suzanne D. Turner, Eva Kaergel, Linda von Hoff, Micha
Pubblicato in: Leukemia, Numero 32/9, 2018, Pagina/e 1994-2007, ISSN 0887-6924
Editore: Nature Publishing Group
DOI: 10.1038/s41375-018-0045-9

Comment on “ALK is a therapeutic target for lethal sepsis”

Autori: Rafael B. Blasco, Enrico Patrucco, Ines Mota, Wei-Tien Tai, Roberto Chiarle
Pubblicato in: Science Translational Medicine, Numero 10/471, 2018, Pagina/e eaar4321, ISSN 1946-6234
Editore: American Association for the Advancement of Science
DOI: 10.1126/scitranslmed.aar4321

Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma

Autori: Nicole Prutsch, Elisabeth Gurnhofer, Tobias Suske, Huan Chang Liang, Michaela Schlederer, Simone Roos, Lawren C. Wu, Ingrid Simonitsch-Klupp, Andrea Alvarez-Hernandez, Christoph Kornauth, Dario A. Leone, Jasmin Svinka, Robert Eferl, Tanja Limberger, Astrid Aufinger, Nitesh Shirsath, Peter Wolf, Thomas Hielscher, Fritz Aberger, Johannes Schmoellerl, Dagmar Stoiber, Birgit Strobl, Ulrich Jäger, Phi
Pubblicato in: Leukemia, Numero 33/3, 2019, Pagina/e 696-709, ISSN 0887-6924
Editore: Nature Publishing Group
DOI: 10.1038/s41375-018-0239-1

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Autori: Peng Liu, Liwei Zhao, Jonathan Pol, Sarah Levesque, Adriana Petrazzuolo, Christina Pfirschke, Camilla Engblom, Steffen Rickelt, Takahiro Yamazaki, Kristina Iribarren, Laura Senovilla, Lucillia Bezu, Erika Vacchelli, Valentina Sica, Andréa Melis, Tiffany Martin, Lin Xia, Heng Yang, Qingqing Li, Jinfeng Chen, Sylvère Durand, Fanny Aprahamian, Deborah Lefevre, Sophie Broutin, Angelo Paci, Amaury Bo
Pubblicato in: Nature Communications, Numero 10/1, 2019, ISSN 2041-1723
Editore: Nature Publishing Group
DOI: 10.1038/s41467-019-09838-y

Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma

Autori: Matteo Menotti, Chiara Ambrogio, Taek-Chin Cheong, Chiara Pighi, Ines Mota, Seth H. Cassel, Mara Compagno, Qi Wang, Riccardo Dall’Olio, Valerio G. Minero, Teresa Poggio, Geeta Geeta Sharma, Enrico Patrucco, Cristina Mastini, Ramesh Choudhari, Achille Pich, Alberto Zamo, Roberto Piva, Silvia Giliani, Luca Mologni, Clayton K. Collings, Cigall Kadoch, Carlo Gambacorti-Passerini, Luigi D. Notarangel
Pubblicato in: Nature Medicine, Numero 25/1, 2019, Pagina/e 130-140, ISSN 1078-8956
Editore: Nature Publishing Group
DOI: 10.1038/s41591-018-0262-9

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Autori: Peng Liu, Liwei Zhao, Jonathan Pol, Sarah Levesque, Adriana Petrazzuolo, Christina Pfirschke, Camilla Engblom, Steffen Rickelt, Takahiro Yamazaki, Kristina Iribarren, Laura Senovilla, Lucillia Bezu, Erika Vacchelli, Valentina Sica, Andréa Melis, Tiffany Martin, Lin Xia, Heng Yang, Qingqing Li, Jinfeng Chen, Sylvère Durand, Fanny Aprahamian, Deborah Lefevre, Sophie Broutin, Angelo Paci, Amaury Bo
Pubblicato in: Nature Communications, Numero 10/1, 2019, ISSN 2041-1723
Editore: Nature Publishing Group
DOI: 10.1038/s41467-019-09415-3

Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms

Autori: Alessandro Prestipino, Alica J. Emhardt, Konrad Aumann, David O’Sullivan, Sivahari P. Gorantla, Sandra Duquesne, Wolfgang Melchinger, Lukas Braun, Slavica Vuckovic, Melanie Boerries, Hauke Busch, Sebastian Halbach, Sandra Pennisi, Teresa Poggio, Petya Apostolova, Pia Veratti, Michael Hettich, Gabriele Niedermann, Mark Bartholomä, Khalid Shoumariyeh, Jonas S. Jutzi, Julius Wehrle, Christine Dier
Pubblicato in: Science Translational Medicine, Numero 10/429, 2018, Pagina/e eaam7729, ISSN 1946-6234
Editore: American Association for the Advancement of Science
DOI: 10.1126/scitranslmed.aam7729

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

Autori: Barbara Maurer, Harini Nivarthi, Bettina Wingelhofer, Ha Thi Than Pham, Michaela Schlederer, Tobias Suske, Reinhard Grausenburger, Ana-Iris Schiefer, Michaela Prchal-Murphy, Doris Chen, Susanne Winkler, Olaf Merkel, Christoph Kornauth, Maximilian Hofbauer, Birgit Hochgatterer, Gregor Hoermann, Andrea Hoelbl-Kovacic, Jana Prochazkova, Cosimo Lobello, Abbarna A. Cumaraswamy, Johanna Latzka, Melitta
Pubblicato in: Haematologica, 2019, Pagina/e haematol.2019.216986, ISSN 0390-6078
Editore: Ferrata Storti Foundation
DOI: 10.3324/haematol.2019.216986

Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells

Autori: Luca Mologni, Mariantonia Costanza, Geeta Geeta Sharma, Michela Viltadi, Luca Massimino, Stefania Citterio, Stefania Purgante, Hima Raman, Alessandra Pirola, Massimo Zucchetti, Rocco Piazza, Carlo Gambacorti-Passerini
Pubblicato in: Neoplasia, Numero 20/5, 2018, Pagina/e 467-477, ISSN 1476-5586
Editore: Elsevier
DOI: 10.1016/j.neo.2018.02.009

NPM-ALK-reactive T-cell responses in children and adolescents with NPM-ALK positive anaplastic large cell lymphoma

Autori: Vijay Kumar Singh, Sebastian Werner, Simone Schwalm, Volker Lennerz, Stephanie Ruf, Serena Stadler, Holger Hackstein, Alfred Reiter, Thomas Wölfel, Christine Damm-Welk, Wilhelm Woessmann
Pubblicato in: OncoImmunology, Numero 8/9, 2019, Pagina/e e1625688, ISSN 2162-402X
Editore: Taylor and Francis
DOI: 10.1080/2162402x.2019.1625688

An anaplastic cardiac large cell lymphoma: A case report and analysis of cardiac involvement in newly diagnosed non-Hodgkin’s lymphoma from the Czech Lymphoma Study Group (CLSG) database

Autori: Lobello C, Janikova A, Kren L, Hermanova M, Sprlakova-Pukova A, Krejci J, Pospisilova S, Pytlik R, Hamouzova M, Belada D, Prochazka V, Duras J, Mocikova H, Trneny M
Pubblicato in: Journal of Cancer Research & Therapy, Numero 5/10, 2017, Pagina/e 66-71, ISSN 2052-4994
Editore: Noble Research
DOI: 10.14312/2052-4994.2017-13

Phosphoproteome and gene expression profiling of ALK inhibition in neuroblastoma cell lines reveals conserved oncogenic pathways

Autori: Jimmy Van den Eynden, Ganesh Umapathy, Arghavan Ashouri, Diana Cervantes-Madrid, Joanna Szydzik, Kristina Ruuth, Jan Koster, Erik Larsson, Jikui Guan, Ruth H. Palmer, Bengt Hallberg
Pubblicato in: Science Signaling, Numero 11/557, 2018, Pagina/e eaar5680, ISSN 1937-9145
Editore: American Association for the Advancement of Science
DOI: 10.1126/scisignal.aar5680

Repotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells

Autori: Diana Cervantes-Madrid, Joanna Szydzik, Dan Emil Lind, Marcus Borenäs, Mats Bemark, Jean Cui, Ruth Helen Palmer, Bengt Hallberg
Pubblicato in: Scientific Reports, Numero 9/1, 2019, ISSN 2045-2322
Editore: Nature Publishing Group
DOI: 10.1038/s41598-019-55060-7

Existence of reprogrammed lymphoma stem cells in a murine ALCL-like model

Autori: Stefanie Kreutmair, Cathrin Klingeberg, Teresa Poggio, Geoffroy Andrieux, Alexander Keller, Cornelius Miething, Marie Follo, Dietmar Pfeifer, Khalid Shoumariyeh, Claudia Lengerke, Irene Gonzalez-Menendez, Falko Fend, Robert Zeiser, Suzanne D. Turner, Leticia Quintanilla-Martinez, Melanie Boerries, Justus Duyster, Anna L. Illert
Pubblicato in: Leukemia, 2020, ISSN 0887-6924
Editore: Nature Publishing Group
DOI: 10.1038/s41375-020-0789-x

NPM1c alters FLT3-D835Y localization and signaling in acute myeloid leukemia

Autori: Alina Rudorf, Tony Andreas Müller, Cathrin Klingeberg, Stefanie Kreutmair, Teresa Poggio, Sivahari Prasad Gorantla, Tamina Rückert, Annette Schmitt-Graeff, Anina Gengenbacher, Peter Paschka, Claudia Baldus, Robert Zeiser, George S. Vassiliou, Allan Bradley, Justus Duyster, Anna Lena Illert
Pubblicato in: Blood, Numero 134/4, 2019, Pagina/e 383-388, ISSN 0006-4971
Editore: American Society of Hematology
DOI: 10.1182/blood.2018883140

Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas

Autori: Teresa Poggio, Justus Duyster, Anna Illert
Pubblicato in: Cancers, Numero 10/9, 2018, Pagina/e 339, ISSN 2072-6694
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers10090339

Proteomic Phosphosite Analysis Identified Crucial NPM-ALK-Mediated NIPA Serine and Threonine Residues

Autori: Anina Gengenbacher, Alina Müller-Rudorf, Teresa Poggio, Linda Gräßel, Veronica I. Dumit, Stefanie Kreutmair, Lena J. Lippert, Justus Duyster, Anna L. Illert
Pubblicato in: International Journal of Molecular Sciences, Numero 20/16, 2019, Pagina/e 4060, ISSN 1422-0067
Editore: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms20164060

Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis

Autori: Ivonne A. Montes-Mojarro, Wook Youn Kim, Falko Fend, Leticia Quintanilla-Martinez
Pubblicato in: Seminars in Diagnostic Pathology, Numero 37/1, 2020, Pagina/e 32-46, ISSN 0740-2570
Editore: W. B. Saunders Co., Ltd.
DOI: 10.1053/j.semdp.2019.12.004

EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK+ and ALK− anaplastic large-cell lymphoma

Autori: Janine Schmidt, Irina Bonzheim, Julia Steinhilber, Ivonne A Montes-Mojarro, Carlos Ortiz-Hidalgo, Wolfram Klapper, Falko Fend, Leticia Quintanilla-Martínez
Pubblicato in: Laboratory Investigation, Numero 97/9, 2017, Pagina/e 1095-1102, ISSN 0023-6837
Editore: Nature Publishing Group
DOI: 10.1038/labinvest.2017.54

Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America

Autori: Ivonne A. Montes-Mojarro, Bo-Jung Chen, Ana F. Ramirez-Ibarguen, Carmen M. Quezada-Fiallos, Wendy B. Pérez-Báez, Daniela Dueñas, Sandro Casavilca-Zambrano, Marcela Ortiz-Mayor, Erica Rojas-Bilbao, Hernan García-Rivello, Maria F. Metrebian, Marina Narbaitz, Carlos Barrionuevo, Carmen Lome-Maldonado, Irina Bonzheim, Falko Fend, Julia Steinhilber, Leticia Quintanilla-Martinez
Pubblicato in: Modern Pathology, Numero 33/5, 2020, Pagina/e 781-791, ISSN 0893-3952
Editore: Nature Publishing Group
DOI: 10.1038/s41379-019-0415-5

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases

Autori: Wook Youn Kim, Ivonne A. Montes-Mojarro, Falko Fend, Leticia Quintanilla-Martinez
Pubblicato in: Frontiers in Pediatrics, Numero 7, 2019, ISSN 2296-2360
Editore: Frontiers
DOI: 10.3389/fped.2019.00071

A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive Lung Cancer with Acquired Resistance to Brigatinib Also Confers Primary Resistance to Lorlatinib

Autori: Geeta G. Sharma, Diego Cortinovis, Francesco Agustoni, Giulia Arosio, Matteo Villa, Nicoletta Cordani, Paolo Bidoli, William H. Bisson, Fabio Pagni, Rocco Piazza, Carlo Gambacorti-Passerini, Luca Mologni
Pubblicato in: Journal of Thoracic Oncology, Numero 14/11, 2019, Pagina/e e257-e259, ISSN 1556-0864
Editore: Lippincott Williams & Wilkins Ltd.
DOI: 10.1016/j.jtho.2019.06.028

We shall overcome (drug resistance) some day

Autori: Geeta G. Sharma, Luca Mologni
Pubblicato in: Oncotarget, Numero 10/2, 2019, Pagina/e 84-85, ISSN 1949-2553
Editore: Impact Journals
DOI: 10.18632/oncotarget.26550

Lorlatinib Treatment Elicits Multiple On- and Off-Target Mechanisms of Resistance in ALK-Driven Cancer

Autori: Sara Redaelli, Monica Ceccon, Marina Zappa, Geeta G. Sharma, Cristina Mastini, Mario Mauri, Marion Nigoghossian, Luca Massimino, Nicoletta Cordani, Francesca Farina, Rocco Piazza, Carlo Gambacorti-Passerini, Luca Mologni
Pubblicato in: Cancer Research, Numero 78/24, 2018, Pagina/e 6866-6880, ISSN 0008-5472
Editore: American Association for Cancer Research
DOI: 10.1158/0008-5472.can-18-1867